Evidence map›Paper›PMID 41436423›Full record

ArticleCell death & disease2025

Correction: Mitochondrial Lon-induced mitophagy benefits hypoxic resistance via Ca

Ananth Ponneri Babuharisankar, Cheng-Liang Kuo, Han-Yu Chou, Vidhya Tangeda, Chi-Chen Fan, Chung-Hsing Chen, Yung-Hsi Kao, Alan Yueh-Luen Lee

Abstract readPublished Erratum
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Multifaceted regulation of immune cells in radiation-induced pulmonary fibrosis: from mechanistic insights to targeted therapies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Ananth Ponneri BabuharisankarPhD program in molecular medicine, NHRI & NCU, Taoyuan, Taiwan.
Cheng-Liang KuoNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
Han-Yu ChouNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
Vidhya TangedaPhD program in molecular medicine, NHRI & NCU, Taoyuan, Taiwan.
Chi-Chen FanDepartment of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu, 300, Taiwan.
Chung-Hsing ChenNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
Yung-Hsi KaoPhD program in molecular medicine, NHRI & NCU, Taoyuan, Taiwan.
Alan Yueh-Luen LeePhD program in molecular medicine, NHRI & NCU, Taoyuan, Taiwan. alanylee@nhri.edu.tw.ORCID http://orcid.org/0000-0003-0252-0571

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41436423
PMCPMC12727722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.